Stay updated on Lumasiran in Primary Hyperoxaluria Type 1: Clinical Trial
Sign up to get notified when there's something new on the Lumasiran in Primary Hyperoxaluria Type 1: Clinical Trial page.

Latest updates to the Lumasiran in Primary Hyperoxaluria Type 1: Clinical Trial page
- Check4 days agoChange DetectedAdded a government funding status notice and updated the site revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check11 days agoChange DetectedThe history page now shows a glossary option, green highlights for additions and red highlights for deletions, and a revised 'Revision' banner to indicate version changes; these changes are cosmetic and do not affect the underlying study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRevision: v3.3.4 has been added to the record history, replacing the previous v3.3.3 entry, a minor metadata update that does not affect study data, status, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check46 days agoChange DetectedThe page now shows Revision: v3.3.3. The HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed.SummaryDifference0.1%

- Check68 days agoChange DetectedThe page history shows a new revision v3.3.2 was added and the previous v3.3.1 removed, reflecting a minor update to the record history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check75 days agoChange DetectedRevision: v3.3.1 appears in the page footer, replacing v3.2.0. This is a minor version update and does not affect study information or page functionality.SummaryDifference0.0%

Stay in the know with updates to Lumasiran in Primary Hyperoxaluria Type 1: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lumasiran in Primary Hyperoxaluria Type 1: Clinical Trial page.